1 / 17

Journal Club

Journal Club. Alcohol, Other Drugs, and Health: Current Evidence May–June 2011. Featured Article. Association of Alcohol Intake With Pancreatic Cancer Mortality in Never Smokers Gapstur SM, et al. Arch Intern Med. 2011;171(5):444–451. Study Objective.

adam-monroe
Télécharger la présentation

Journal Club

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2011

  2. Featured Article Association of Alcohol Intake With Pancreatic Cancer Mortality in Never Smokers Gapstur SM, et al. Arch Intern Med. 2011;171(5):444–451.

  3. Study Objective • To examine the relationship between alcohol consumption and pancreatic cancer and to assess whether the association varied by beverage type or as a result of tobacco smoking.

  4. Study Design • Analysis of cancer mortality data from the Cancer Prevention Study II, a prospective study of 1,030,467 US adults aged ≥30 years followed from 1982–2006.

  5. Assessing Validity of an Article About Harm • Are the results valid? • What are the results? • How can I apply the results to patient care?

  6. Are the Results Valid? • Did the investigators demonstrate similarity in all known determinants of outcomes? Did they adjust for differences in the analysis? • Were exposed patients equally likely to be identified in the two groups? • Were the outcomes measured in the same way in the groups being compared? • Was follow-up sufficiently complete?

  7. Did the investigators demonstrate similarity in all known determinants of outcomes? Did they adjust for differences in the analysis? • Yes. • Multivariable-adjusted relative risks (RRs) and 95% confidence intervals (CIs) were computed using Cox proportional hazards regression analysis controlling for age, sex, race/ethnicity, education, marital status, body mass index, family history of pancreatic cancer, and personal history of gallstones, diabetes mellitus, or smoking.

  8. Were exposed patients equally likely to be identified in the groups? • Yes. • All participants completed a baseline survey including the question, “How many cups, glasses, or drinks of these beverages do you usually drink a day, and for how many years?” Intake amounts of beer, wine, and liquor were assessed separately. • Participants who wrote “0” or left the alcohol consumption section blank* were classified as nondrinkers. • Participants who did not provide interpretable alcohol-intake information, who reported past but not current alcohol intake, or who reported implausibly high alcohol intake (≥30 drinks per day) were excluded from this analysis. *A total of 394,032 participants left the alcohol section blank.

  9. Were the outcomes measured in the same way in the groups being compared? • Yes. • Mortality outcomes were assessed via personal inquiry from 1982–1988 then through linkage to the National Death Registry through 2006.

  10. Was follow-up sufficiently complete? • Yes. • Death certificates and cause-of-death codes were obtained for >99% of known deaths in the sample.

  11. What are the Results? • How strong is the association between exposure and outcomes? • How precise is the estimate of the risk?

  12. How strong is the association between exposure and outcome? How precise is the estimate of the risk? *Adjusted for age, sex, race/ethnicity, education, marital status, body mass index, family history of pancreatic cancer, and history of gallstones or diabetes mellitus. †Adjusted for age, sex, race/ethnicity, education, marital status, body mass index, family history of pancreatic cancer, and history of gallstones, diabetes mellitus, or smoking.

  13. How Can I Apply the Results to Patient Care? • Were the study patients similar to the patients in my practice? • Was the duration of follow-up adequate? • What was the magnitude of the risk? • Should I attempt to stop the exposure?

  14. Were the study patients similar to the patients in my practice? • The sample included 576,697 women and 453,770 men aged ≥30 years from across the US and including the District of Columbia and Puerto Rico.

  15. Was the duration of follow-up adequate? • Follow-up was 14 years.

  16. What was the magnitude of the risk? • Never smokers had a 36% higher risk of pancreatic cancer mortality associated with consumption of 3 or more drinks per day (largely confined to those who drank liquor) compared with nondrinkers. • Ever smokers had a 16% higher risk after adjustment for smoking history and other covariates.

  17. Should I attempt to stop the exposure? • Patients should be counseled that consumption of 3 or more drinks per day of liquor is associated with an increased risk of pancreatic cancer compared to not consuming alcohol.

More Related